Belinda Cancilla

3.7k total citations · 1 hit paper
38 papers, 2.7k citations indexed

About

Belinda Cancilla is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Belinda Cancilla has authored 38 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Belinda Cancilla's work include Fibroblast Growth Factor Research (6 papers), Cancer Cells and Metastasis (5 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Belinda Cancilla is often cited by papers focused on Fibroblast Growth Factor Research (6 papers), Cancer Cells and Metastasis (5 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Belinda Cancilla collaborates with scholars based in United States, Australia and Netherlands. Belinda Cancilla's co-authors include Gail P. Risbridger, Felix Chu, Yongchang Shi, Peiwen Yu, Alison Joly, Frauke Bentzien, F. Michael Yakes, Stefan Engst, Andrew You and Yu-Chien Chou and has published in prestigious journals such as Nature, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Belinda Cancilla

38 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth

2011 1.0k citations F. Michael Yakes, Jason Chen et al. Molecular Cancer Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Belinda Cancilla United States	18	1.5k	1.1k	673	377	347	38	2.7k
Shiu‐Feng Huang Taiwan	29	1.4k 0.9×	1.2k 1.1×	944 1.4×	596 1.6×	120 0.3×	78	2.9k
Frauke Bentzien United States	10	821 0.5×	665 0.6×	522 0.8×	298 0.8×	372 1.1×	12	2.1k
Umesh Bhanot United States	18	1.0k 0.7×	704 0.6×	499 0.7×	678 1.8×	185 0.5×	44	1.9k
Vincenzo Damiano Italy	26	1.4k 0.9×	1.9k 1.6×	1.2k 1.7×	459 1.2×	122 0.4×	62	3.2k
Yoshihiko Kitajima Japan	29	1.6k 1.1×	956 0.8×	413 0.6×	836 2.2×	181 0.5×	85	2.7k
M Imamura Japan	27	1.5k 1.0×	1.2k 1.1×	552 0.8×	720 1.9×	310 0.9×	79	2.9k
Silvia Benvenuti Italy	20	969 0.6×	1.6k 1.4×	923 1.4×	436 1.2×	425 1.2×	40	2.6k
Zhaoshi Zeng United States	27	1.0k 0.7×	1.3k 1.1×	397 0.6×	897 2.4×	415 1.2×	37	2.6k
Shinji Takeuchi Japan	26	1.0k 0.7×	948 0.8×	1.1k 1.6×	319 0.8×	158 0.5×	100	2.1k
Laura Boldrini Italy	27	1.2k 0.8×	916 0.8×	733 1.1×	652 1.7×	104 0.3×	98	2.5k

Countries citing papers authored by Belinda Cancilla

Since Specialization

Citations

This map shows the geographic impact of Belinda Cancilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belinda Cancilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belinda Cancilla more than expected).

Fields of papers citing papers by Belinda Cancilla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belinda Cancilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belinda Cancilla. The network helps show where Belinda Cancilla may publish in the future.

Co-authorship network of co-authors of Belinda Cancilla

This figure shows the co-authorship network connecting the top 25 collaborators of Belinda Cancilla. A scholar is included among the top collaborators of Belinda Cancilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belinda Cancilla. Belinda Cancilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cho, Yeonhee, Zhongzheng Cao, Xin Luo, et al.. (2024). NLRP10 maintains epidermal homeostasis by promoting keratinocyte survival and P63-dependent differentiation and barrier function. Cell Death and Disease. 15(10). 759–759. 1 indexed citations

Fischer, Marcus, Belinda Cancilla, Vincent Yeung, et al.. (2017). WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death. Science Advances. 3(6). e1700090–e1700090. 122 indexed citations

Lim, Jing Shan, Alvaro Ibaseta, Marcus Fischer, et al.. (2017). Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. Nature. 545(7654). 360–364. 311 indexed citations

Fischer, Marcus, Vincent Yeung, Fiore Cattaruzza, et al.. (2017). RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations. Scientific Reports. 7(1). 15270–15270. 37 indexed citations

Yen, Wan-Ching, Marcus Fischer, Fumiko Axelrod, et al.. (2015). Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency. Clinical Cancer Research. 21(9). 2084–2095. 195 indexed citations

Srivastava, Minu K., Christopher L. Murriel, Julie M. Roda, et al.. (2015). Abstract 255: Dual targeting of Delta-like ligand 4 (DLL4) and programmed death 1(PD1) inhibits tumor growth and generates enhanced long-term immunological memory. Cancer Research. 75(15_Supplement). 255–255. 1 indexed citations

Bentzien, Frauke, Yongchang Shi, Peiwen Yu, et al.. (2013). In Vitro and In Vivo Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer. Thyroid. 23(12). 1569–1577. 102 indexed citations

Wallace, Breanna, Min Wang, Jennifer Cain, et al.. (2013). Abstract 213: Novel NOTCH3 activating mutations identified in tumors sensitive to OMP-59R5, a monoclonal antibody targeting the Notch2 and Notch3 receptors.. Cancer Research. 73(8_Supplement). 213–213. 1 indexed citations

Yakes, F. Michael, Jason Chen, Jenny Tan, et al.. (2011). Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth. Molecular Cancer Therapeutics. 10(12). 2298–2308. 1036 indexed citations breakdown →

10.

Wu, Bingyan, Belinda Cancilla, Valentina Vysotskaia, et al.. (2009). Correlative tumor molecular profiling and plasma biomarker analysis in a phase II study of XL184 in patients with progressive or recurrent glioblastoma multiforme (GBM). Journal of Clinical Oncology. 27(15_suppl). 2049–2049. 6 indexed citations

11.

Müller, Thomas, Samuel E. DePrimo, Peiwen Yu, et al.. (2009). Abstract B269: Pharmacodynamic and correlative biomarker analyses in clinical trials of XL184, an oral, potent inhibitor of MET, VEGFR2, and RET. Molecular Cancer Therapeutics. 8(12_Supplement). B269–B269. 4 indexed citations

12.

Küchler, Axel M., Evisa Gjini, Josi Peterson-Maduro, et al.. (2006). Development of the Zebrafish Lymphatic System Requires Vegfc Signaling. Current Biology. 16(12). 1244–1248. 206 indexed citations

13.

Cancilla, Belinda, et al.. (2001). Fibroblast growth factor receptors and their ligands in the adult rat kidney. Kidney International. 60(1). 147–155. 48 indexed citations

14.

Cancilla, Belinda, Renea A. Jarred, Hong Wang, et al.. (2001). Regulation of Prostate Branching Morphogenesis by Activin A and Follistatin. Developmental Biology. 237(1). 145–158. 61 indexed citations

15.

Mellor, Sally L., Mark Cranfield, John Pedersen, et al.. (2000). Localization of Activin β_A-,β_B-, andβ_C-Subunits in Human Prostate and Evidence for Formation of New Activin Heterodimers ofβ_C-Subunit¹. The Journal of Clinical Endocrinology & Metabolism. 85(12). 4851–4858. 92 indexed citations

16.

Cancilla, Belinda, Andrew Davies, M. Ford-Perriss, & Gail P. Risbridger. (2000). Discrete cell- and stage-specific localisation of fibroblast growth factors and receptor expression during testis development. Journal of Endocrinology. 164(2). 149–159. 43 indexed citations

17.

Jarred, Renea A., Belinda Cancilla, Gail S. Prins, et al.. (2000). Evidence That Estrogens Directly Alter Androgen-Regulated Prostate Development*. Endocrinology. 141(9). 3471–3477. 77 indexed citations

18.

Cancilla, Belinda, M. Ford-Perriss, & John F. Bertram. (1999). Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney. Kidney International. 56(6). 2025–2039. 57 indexed citations

19.

Cancilla, Belinda & Gail P. Risbridger. (1998). Differential Localization of Fibroblast Growth Factor Receptor-i, -2, -3, and -4 in Fetal, Immature, and Adult Rat Testes1. Biology of Reproduction. 58(5). 1138–1145. 42 indexed citations

20.

Alcorn, Daine, Belinda Cancilla, Brian Key, et al.. (1996). Light-microscopic immunolocalization of fibroblast growth factor-1 and -2 in adult rat kidney. Cell and Tissue Research. 285(2). 179–187. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact